2025-04-08 18:49:38
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Norris Medicines Q3FY22 loss at Rs. 18.73 lakhs
Posted On : 2022-02-13 12:04:35( TIMEZONE : IST )
NORRIS MEDICINES LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 1.5211 crores during the period ended December 31, 2021 as compared to Rs. 2.1991 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -0.1873 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -0.7886 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -0.19 for the period ended December 31, 2021 as compared to Rs. -0.79 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 1.5211 crs | ₹2.1991 crs |  -30.83% |
| Net Profit | ₹-0.1873 crs | ₹-0.7886 crs |  76.25% |
| EPS | ₹-0.19 | ₹-0.79 | 75.95% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 1.5211 crores during the period ended December 31, 2021 as compared to Rs.4.6705 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-0.1873 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-0.2421 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-0.19 for the period ended December 31, 2021 as compared to Rs.-0.24 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 1.5211 crs | ₹4.6705 crs | -67.43% |
| Net Profit | ₹-0.1873 crs | ₹-0.2421 crs | 22.64% |
| EPS | ₹-0.19 | ₹-0.24 | 20.83% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.8.6301 crores during the 9 Months period ended December 31, 2021 as compared to Rs.9.7027 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-1.0306 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-1.7875 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.-1.03 for the 9 Months period ended December 31, 2021 as compared to Rs.-1.79 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹8.6301 crs | ₹9.7027 crs | -11.05% |
| Net Profit | ₹-1.0306 crs | ₹-1.7875 crs | 42.34% |
| EPS | ₹-1.03 | ₹-1.79 | 42.46% |
Shares of NORRIS MEDICINES LTD. was last trading in BSE at Rs. 35.00 as compared to the previous close of Rs. 33.35. The total number of shares traded during the day was 3149 in over 25 trades.
The stock hit an intraday high of Rs. 35.00 and intraday low of 35.00. The net turnover during the day was Rs. 110215.00.
